Cognition Thought Leadership

Conversations: Fireside Video Chats

The new “Conversations” video series will feature virtual fireside chats with neuroscience experts who will discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions. Please use the form at the bottom of our webpage you submit your comments or feedback.

Please note, our podcast series does not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately.

Episode 6: Geographic Atrophy: New Strategies to Protect the Retina (a two-part series)

Featuring:
Anthony Caggiano, M.D., Ph.D.
Cognition Therapeutics
Chief Medical Officer
C. Gustavo De Moraes, M.D., Ph.D. (moderator)
Columbia University and Ora (CRO)
Associate Professor of Clinical Ophthalmology
Chief Medical Officer
Jeffrey S. Heier, M.D.
Ophthalmic Consultants of Boston
Director of the Vitreoretinal Service & Retina Research
Peter K. Kaiser, M.D.
Cleveland Clinic Lerner College of Medicine
Chaney Family Endowed Chair in Ophthalmology Research
and Professor of Ophthalmology

Episode 5: Exploring the Effects of CT1812 on Alzheimer’s Disease Processes: Proteomics and Pathways of Neurodegeneration

Featuring:
Mary Hamby, Ph.D.
Cognition Therapeutics
Vice President of Research
Charlotte Teunissen, Ph.D. (moderator)
Amsterdam University Medical Center
Professor of Clinical Neurochemistry
Nicholas Seyfried, Ph.D.
Emory University School of Medicine
Professor of Biochemistry and Neurology
Director of the Emory Integrated Proteomics Core
Henrik Zetterberg, MD, Ph.D.
Gothenburg University
Professor of Neuroscience
Group Leader of the UK Dementia Research Institute
Index:
0:00Introduction
01:53Utility of Proteomic Analysis in Alzheimer’s
03:20Review of Proteomics Findings from AD/PD 2023
08:36Key Learnings

Episode 4: Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies

Featuring:
Anthony Caggiano, M.D., Ph.D.
Cognition Therapeutics
Chief Medical Officer and Head of Research & Development
Brendan Kelley, M.D. (moderator)
University of Texas SW
Vice Chair for Clinical Operations at the Peter O’Donnell Jr. Brain Institute and a Professor in the Department of Neurology
Sarah B. Berman, M.D., Ph.D.
University of Pittsburgh
Associate Professor in the Departments of Neurology and Clinical & Translational Science and Director of DLB Programs at the ARDC
James Leverenz, M.D.
Cleveland Clinic
Director of the Lou Ruvo Center for Brain Health
David Shprecher, D.O.
Banner Sun Health Research Institute
Movement Disorder Director and a Clinical Associate Professor at the University of Arizona
Index:
0:00 Introduction
01:09 Part I: The Intersection of Alzheimer’s and DLB
07:23 Biomarker Tests for DLB
09:11 Part II: Practical insights for community HCPs
09:40 Frequency of missed or delayed diagnosis of DLB
12:48 Facets of patient-reported memory loss
19:46 Nuances of psychological symptoms
24:23 Cognitive Fluctuations

Episode 3: What if it’s not Alzheimer’s? The Caregiver’s Perspective on Lewy Body Dementia

Featuring:
Lisa Ricciardi
Cognition Therapeutics
President & Chief Executive Officer
Norma Loeb
Lewy Body Dementia Resource Center
Founder and Executive Director
Mary Lou Falcone
M.L. FALCONE, Public Relations
Board member, LBD Resource Center
Author of “I Didn’t See It Coming, a Memoir of Love, Loss,
and Lewy Body Dementia”
Index:
0:00 Introduction
2:30 Key symptoms and signs of Lewy body dementia
9:44 The importance of an accurate diagnosis
13:30 Preparing for a doctor visit
15:30 Resources, support and caring for the caregiver

Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches

Featuring:
Anthony Caggiano, M.D., Ph.D.
Cognition Therapeutics
Chief Medical Officer and Head of R&D
Christopher H. van Dyck, M.D.
Yale University School of Medicine
Professor of Psychiatry, Neurology, and Neuroscience; Director of the Division of Aging and Geriatric Psychiatry; Director of the Alzheimer’s Disease Research Center
Anton P. Porsteinsson, M.D.
University of Rochester School of
Medicine and Dentistry
William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine; and Director of the Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
Index:
0:00Introduction
1:47Reactions to lecanemab results
3:48Impact of targeting plaque
6:46Potentially complementary strategies
11:24Future of Alzheimer’s therapies
13:40Conclusion
Episode 1: Dementia with Lewy Bodies
Featuring:
Anthony Caggiano, M.D., Ph.D.
Cognition Therapeutics
Chief Medical Officer and Head of R&D
James Galvin, M.D., MPH
University of Miami Miller School
of Medicine
Director of the Comprehensive Center for Brain Health
Principal Investigator of the SHIMMER Study
Index:
0:00Introduction
1:09What is DLB
3:13Diagnostic Challenges
6:38Potential Treatment Strategy
7:48Designing a Clinical Trial
8:42Conclusion

Leadership Editorials

BioTuesdays
By Lisa Ricciardi
February 21, 2023

Investment Reports by Newsweek
By Lisa Ricciardi
February 21, 2023

Drug Discovery and Development Magazine
By Anthony Caggiano
January 4, 2023

MedCity News
By Lisa Ricciardi
October 1, 2022

Questions? Send us an email:

Scroll to Top

Guide to Episode 3:

Key symptoms and signs of Lewy body dementias
Importance of an accurate diagnosis
Preparing for a doctor’s visit
Resources and support for the caregiver
2:28
9:45
13:30
15:35

You are now leaving the Cognition Therapeutics website

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.